RTW INVESTMENTS, LP: 13F holdings
CIK 14932152026Q2
| Positions | 84 |
|---|---|
| Reported value | $11.7bn |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| MDGL MADRIGAL PHARMACEUTICALS INC | 1,993,687 | $1.1bn | 9.1% |
| ARGX ARGENX SE | 709,446 | $658.2m | 5.6% |
| PTCT PTC THERAPEUTICS INC | 7,746,415 | $631.9m | 5.4% |
| PTGX PROTAGONIST THERAPEUTICS INC | 5,061,175 | $620.4m | 5.3% |
| CG ONCOLOGY INC | 8,514,590 | $605.0m | 5.2% |
| INSM INSMED INC | 4,842,880 | $516.3m | 4.4% |
| TANGO THERAPEUTICS INC | 13,900,620 | $434.5m | 3.7% |
| SYRE SPYRE THERAPEUTICS INC | 4,251,996 | $377.5m | 3.2% |
| CELCUITY INC | 3,304,903 | $345.8m | 3.0% |
| ERASCA INC | 17,946,754 | $328.8m | 2.8% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1493215")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.